The results showed that the number of senile plaques in the cerebral cortex and hippocampus of APP/PS1 transgenic mice in the melatonin intervention group was significantly reduced compared with that of APP/PS1 transgenic mice in the placebo control group (Figures 1(f) and 1(g)). This evidence concerns the gene APP and Senile plaques.